Literature DB >> 17854770

Potent inhibition of tau fibrillization with a multivalent ligand.

Nicolette S Honson1, Jordan R Jensen, Michael V Darby, Jeff Kuret.   

Abstract

Small-molecule inhibitors of tau fibrillization are under investigation as tools for interrogating the tau aggregation pathway and as potential therapeutic agents for Alzheimer's disease. Established inhibitors include thiacarbocyanine dyes, which can inhibit recombinant tau fibrillization in the presence of anionic surfactant aggregation inducers. In an effort to increase inhibitory potency, a cyclic bis-thiacarbocyanine molecule containing two thiacarbocyanine moieties was synthesized and characterized with respect to tau fibrillization inhibitory activity by electron microscopy and ligand aggregation state by absorbance spectroscopy. Results showed that the inhibitory activity of the bis-thiacarbocyanine was qualitatively similar to a monomeric cyanine dye, but was more potent with 50% inhibition achieved at approximately 80nM concentration. At all concentrations tested in aqueous solution, the bis-thiacarbocyanine collapsed to form a closed clamshell structure. However, the presence of tau protein selectively stabilized the open conformation. These results suggest that the inhibitory activity of bis-thiacarbocyanine results from multivalency, and reveal a route to more potent tau aggregation inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854770      PMCID: PMC2048976          DOI: 10.1016/j.bbrc.2007.08.166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Cyanines during the 1990s: A Review.

Authors:  A Mishra; R K Behera; P K Behera; B K Mishra; G B Behera
Journal:  Chem Rev       Date:  2000-06-14       Impact factor: 60.622

2.  Electron microscopy as a quantitative method for investigating tau fibrillization.

Authors:  Mihaela Necula; Jeff Kuret
Journal:  Anal Biochem       Date:  2004-06-15       Impact factor: 3.365

Review 3.  Hitting multiple targets with multimeric ligands.

Authors:  Heather L Handl; Josef Vagner; Haiyong Han; Eugene Mash; Victor J Hruby; Robert J Gillies
Journal:  Expert Opin Ther Targets       Date:  2004-12       Impact factor: 6.902

4.  Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.

Authors:  Mihaela Necula; Rakez Kayed; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

5.  The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

Authors:  G Carmel; E M Mager; L I Binder; J Kuret
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

6.  Small molecule inhibitors of alpha-synuclein filament assembly.

Authors:  Masami Masuda; Nobuyuki Suzuki; Sayuri Taniguchi; Takayuki Oikawa; Takashi Nonaka; Takeshi Iwatsubo; Shin-ichi Hisanaga; Michel Goedert; Masato Hasegawa
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

7.  Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.

Authors:  Barnaby C H May; Aaron T Fafarman; Septima B Hong; Michael Rogers; Leslie W Deady; Stanley B Prusiner; Fred E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

8.  Anionic micelles and vesicles induce tau fibrillization in vitro.

Authors:  Carmen N Chirita; Mihaela Necula; Jeff Kuret
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

9.  Potency of a tau fibrillization inhibitor is influenced by its aggregation state.

Authors:  Erin E Congdon; Mihaela Necula; Robert D Blackstone; Jeff Kuret
Journal:  Arch Biochem Biophys       Date:  2007-05-25       Impact factor: 4.013

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  8 in total

1.  Azaphilones inhibit tau aggregation and dissolve tau aggregates in vitro.

Authors:  Smita R Paranjape; Andrew P Riley; Amber D Somoza; C Elizabeth Oakley; Clay C C Wang; Thomas E Prisinzano; Berl R Oakley; T Chris Gamblin
Journal:  ACS Chem Neurosci       Date:  2015-04-15       Impact factor: 4.418

Review 2.  Discussions of Fluorescence in Selenium Chemistry: Recently Reported Probes, Particles, and a Clearer Biological Knowledge.

Authors:  Ariq Abdillah; Prasad M Sonawane; Donghyeon Kim; Dooronbek Mametov; Shingo Shimodaira; Yunseon Park; David G Churchill
Journal:  Molecules       Date:  2021-01-28       Impact factor: 4.411

3.  Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors.

Authors:  Kelsey N Schafer; Dhiraj P Murale; Kibong Kim; Katryna Cisek; Jeff Kuret; David G Churchill
Journal:  Bioorg Med Chem Lett       Date:  2011-04-17       Impact factor: 2.823

Review 4.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

5.  Structure-activity relationship of cyanine tau aggregation inhibitors.

Authors:  Edward Chang; Erin E Congdon; Nicolette S Honson; Karen E Duff; Jeff Kuret
Journal:  J Med Chem       Date:  2009-06-11       Impact factor: 7.446

Review 6.  Tau as a therapeutic target in neurodegenerative disease.

Authors:  Diana S Himmelstein; Sarah M Ward; Jody K Lancia; Kristina R Patterson; Lester I Binder
Journal:  Pharmacol Ther       Date:  2012-07-10       Impact factor: 12.310

7.  Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.

Authors:  Charles R Harrington; John M D Storey; Scott Clunas; Kathleen A Harrington; David Horsley; Ahtsham Ishaq; Steven J Kemp; Christopher P Larch; Colin Marshall; Sarah L Nicoll; Janet E Rickard; Michael Simpson; James P Sinclair; Lynda J Storey; Claude M Wischik
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

Review 8.  Untangling tau imaging.

Authors:  Victor L Villemagne; Nobuyuki Okamura; Christopher C Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.